Thursday May 3 | GlobeNewswire
Oxygen Biotherapeutics Secures Long-Term Clinical Supply of Oxycyte
Oxygen Biotherapeutics, Inc. , a development stage biomedical company focused on developing perfluorocarbon-based intravenous and topical drug candidates, today announced it has achieved the critical milestone of securing an exclusive supply of cGMP-compliant Oxycyte , the Company's proprietary perfluorocarbon based emulsion, that will take the ... (more)